Sector Update: Health Care Stocks Decline Pre-Bell Monday

MT Newswires Live

May 05

Health care stocks declined pre-bell Monday as the Health Care Select Sector SPDR Fund (XLV) was 0.2% lower and the iShares Biotechnology ETF (IBB) was down 0.8% recently.

Teva Pharmaceutical (TEVA) and Alvotech (ALVO) said Selarsdi has been approved by the US Food and Drug administration as interchangeable with the reference biologic Stelara. Teva Pharmaceutical shares were up over 5% and Alvotech shares were over 2% higher premarket.

Axsome Therapeutics (AXSM) shares advanced by over 4% after the company reported a narrower Q1 net loss as revenue increased.

PTC Therapeutics (PTCT) said a phase 2 study of PTC518, or votoplam, in stage 2 and 3 Huntington's disease met its primary endpoint of reduction in blood Huntingtin protein levels at week 12. Shares of PTC Therapeutics fell by 22% premarket.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/news/2533582318"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2533582318\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2533582318?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-05-05 21:22","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2533582318","market":"us","top_or_hot":-1,"title":"Sector Update: Health Care Stocks Decline Pre-Bell Monday","media":"MT Newswires Live","content":"<html><body><p> Health care stocks declined pre-bell Monday as the Health Care Select Sector SPDR Fund (XLV) was 0.2% lower and the <a href=\"https://laohu8.com/S/EEMA\">iShares</a> Biotechnology ETF (IBB) was down 0.8% recently.</p><p>Teva Pharmaceutical (TEVA) and <a href=\"https://laohu8.com/S/ALVO\">Alvotech</a> (ALVO) said Selarsdi has been approved by the US Food and Drug administration as interchangeable with the reference biologic Stelara. Teva Pharmaceutical shares were up over 5% and Alvotech shares were over 2% higher premarket.</p><p>Axsome <a href=\"https://laohu8.com/S/LENZ\">Therapeutics</a> (AXSM) shares advanced by over 4% after the company reported a narrower Q1 net loss as revenue increased.</p><p>PTC Therapeutics (PTCT) said a phase 2 study of PTC518, or votoplam, in stage 2 and 3 Huntington's disease met its primary endpoint of reduction in blood Huntingtin protein levels at week 12. Shares of PTC Therapeutics fell by 22% premarket.</p></body></html>","source":"mtnewswires_news","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Sector Update: Health Care Stocks Decline Pre-Bell Monday</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nSector Update: Health Care Stocks Decline Pre-Bell Monday\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1092851196\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">MT Newswires Live </p>\n<p class=\"h-time\">2025-05-05 21:22</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html><body><p> Health care stocks declined pre-bell Monday as the Health Care Select Sector SPDR Fund (XLV) was 0.2% lower and the <a href=\"https://laohu8.com/S/EEMA\">iShares</a> Biotechnology ETF (IBB) was down 0.8% recently.</p><p>Teva Pharmaceutical (TEVA) and <a href=\"https://laohu8.com/S/ALVO\">Alvotech</a> (ALVO) said Selarsdi has been approved by the US Food and Drug administration as interchangeable with the reference biologic Stelara. Teva Pharmaceutical shares were up over 5% and Alvotech shares were over 2% higher premarket.</p><p>Axsome <a href=\"https://laohu8.com/S/LENZ\">Therapeutics</a> (AXSM) shares advanced by over 4% after the company reported a narrower Q1 net loss as revenue increased.</p><p>PTC Therapeutics (PTCT) said a phase 2 study of PTC518, or votoplam, in stage 2 and 3 Huntington's disease met its primary endpoint of reduction in blood Huntingtin protein levels at week 12. Shares of PTC Therapeutics fell by 22% premarket.</p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"PTCT","symbol_name":"PTC Therapeutics Inc.","start_time":0,"source_url":"https://www.mtnewswires.com/","article_id":"2533582318","we_media_id":"1092851196","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2533582318","pubTimestamp":1746451344,"columns":[],"sourceInfo":{"source_id":"mtnewswires_news","name":"MT Newswires"},"weMediaInfo":{"media_name":"MT Newswires Live","introduction":"The most recognized names in North America, Europe and Asia rely on MT Newswires to power their applications. Better news, better service, better price.","home_visible":1,"id":"1092851196","head_image":"https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e"},"summary":"Health care stocks declined pre-bell Monday as the Health Care Select Sector SPDR Fund  was 0.2% lower and the iShares Biotechnology ETF  was down 0.8% recently.Teva Pharmaceutical  and Alvotech  said Selarsdi has been approved by the US Food and Drug administration as interchangeable with the reference biologic Stelara. Teva Pharmaceutical shares were up over 5% and Alvotech shares were over 2% higher premarket.Axsome Therapeutics  shares advanced by over 4% after the company reported a narrower Q1 net loss as revenue increased.PTC Therapeutics  said a phase 2 study of PTC518, or votoplam, in stage 2 and 3 Huntington's disease met its primary endpoint of reduction in blood Huntingtin protein levels at week 12. Shares of PTC Therapeutics fell by 22% premarket.","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"PTCT":"PTC Therapeutics Inc.","BK4584":"避孕概念","BK4585":"ETF&股票定投概念","BK4139":"生物科技","BK4566":"资本集团","LU0320765992.SGD":"FTIF - Franklin Biotechnology Discovery A Acc SGD","IBB":"生物科技指数ETF-iShares Nasdaq","BK4505":"高瓴资本持仓","BK4557":"大麻股","LU0109394709.USD":"富兰克林生物科技新领域基金A (acc)","TEVA":"梯瓦制药","BK4596":"哈里斯概念","BK4559":"巴菲特持仓","XLV":"健康照护类股ETF-SPDR","BK4588":"碎股","BK4007":"制药","AXSM":"Axsome Therapeutics, Inc.","LU0889565916.HKD":"FRANKLIN BIOTECHNOLOGY DISCOVERY \"A\" (HKD) ACC","BK4581":"高盛持仓","ALVO":"Alvotech"},"translate_title":"行业更新：医疗保健股周一盘前下跌","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"IBB":0.9,"PTCT":0.9,"TEVA":0.9,"XLV":0.9,"AXSM":0.9,"ALVO":0.9},"content_text":"Health care stocks declined pre-bell Monday as the Health Care Select Sector SPDR Fund (XLV) was 0.2% lower and the iShares Biotechnology ETF (IBB) was down 0.8% recently.Teva Pharmaceutical (TEVA) and Alvotech (ALVO) said Selarsdi has been approved by the US Food and Drug administration as interchangeable with the reference biologic Stelara. Teva Pharmaceutical shares were up over 5% and Alvotech shares were over 2% higher premarket.Axsome Therapeutics (AXSM) shares advanced by over 4% after the company reported a narrower Q1 net loss as revenue increased.PTC Therapeutics (PTCT) said a phase 2 study of PTC518, or votoplam, in stage 2 and 3 Huntington's disease met its primary endpoint of reduction in blood Huntingtin protein levels at week 12. Shares of PTC Therapeutics fell by 22% premarket.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"-1","news_tag":"","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"}}}